A randomized, controlled trial of simvastatin versus rosuvastatin in patients with acute myocardial infarction:the Secondary Prevention of Acute Coronary Events--Reduction of Cholesterol to Key European Targets Trial

Hall, Alistair S, Jackson, Beryl M, Farrin, Amanda J, Efthymiou, Maria, Barth, Julian H, Copeland, Joanne, Bailey, Kristian M, Romaine, Simon P R, Balmforth, Anthony J, McCormack, Terry, Whitehead, Andrew, Flather, Marcus D, Nixon, Jane and , SPACE ROCKET Trial Group (2009) A randomized, controlled trial of simvastatin versus rosuvastatin in patients with acute myocardial infarction:the Secondary Prevention of Acute Coronary Events--Reduction of Cholesterol to Key European Targets Trial. European Journal of Cardiovascular Prevention and Rehabilitation, 16 (6). pp. 712-21. ISSN 1741-8275

Full text not available from this repository. (Request a copy)

Abstract

We sought to evaluate reports that rosuvastatin 10 mg is a more efficacious treatment of hyperlipidaemia than is simvastatin 40 mg, hoping to assess this issue in the previously unstudied context of acute myocardial infarction.

Item Type: Article
Uncontrolled Keywords: aged,biological markers,cholesterol,cholesterol, ldl,female,fluorobenzenes,great britain,humans,hydroxymethylglutaryl-coa reductase inhibitors,hyperlipidemias,male,middle aged,myocardial infarction,odds ratio,practice guidelines as topic,prospective studies,pyrimidines,recurrence,secondary prevention,simvastatin,sulfonamides,time factors,treatment outcome
Faculty \ School: Faculty of Medicine and Health Sciences > Norwich Medical School
Depositing User: Pure Connector
Date Deposited: 06 Jan 2014 14:58
Last Modified: 21 Apr 2020 22:34
URI: https://ueaeprints.uea.ac.uk/id/eprint/46258
DOI: 10.1097/HJR.0b013e3283316ce8

Actions (login required)

View Item View Item